The Cancer Vaccine Institute at the University of Washington Medicine in Seattle, WA, is a group of scientists, doctors, nurses, patients, and philanthropists creating a world where cancer is managed, treated, and ultimately prevented by vaccines. Unlike many organizations focused on the fight against cancer, we connect all three phases of the process under one roof: early discovery, translational research, and clinical trial. This allows us to follow the science full circle, from research bench all the way to patient, and drives research that's faster, more efficiently, and with greater success.
20 years ago, Dr. Nora Disis founded the Tumor Vaccine Group on the vision that it was possible to treat, identify, and heal cancer using the body's own immune system. Today, Dr. Disis is known as the "Mother of Cancer Vaccines" and the Cancer Vaccine Institute is one of the foremost research collaboratives in the world, leading the charge to end cancer.
Today we're focused on targeting cancers that are responsible for more than 50% of the annual diagnosis and deaths in the US: breast, ovarian, prostate, pancreatic, sarcoma, lung, and bladder. We see a future where vaccines are able to prevent and treat cancer.
In the next decade, we expect to see vaccines and immunotherapies readily available to prevent, treat, and cure many types of cancer.
We’re a community harnessing immunotherapy to prevent and treat cancer, one vaccine at a time.
Mary (Nora) Disis, MD
Will Gwin, MD
John Liao, MD, PhD
Laura Riolobos, PhD
Andrew Coveler, MD
Interim Dir, Clinical Trials
Patient Advisory Council
What makes the Cancer Vaccine Institute so special is our connection to the lives that our research impacts. Our Patient Advisory Council is a group of past trial participants who are also experienced patient advocates. They advise us on education and engagement initiatives, and work with us to create a community where participants are supported.
Development Advisory Council
Our Development Advisory Council brings together several of our wonderful supporters — many have a personal connection as their friends or family members have been part of CVI research. They advocate on our behalf, helping to raise and activate the private funds that make a huge difference in the race to find successful cancer treatments.
WHAT'S NEW AT THE CVI